ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Sanofi

Sanofi (1SAN)

90.25
-0.86
(-0.94%)
終了 12月22日 1:30AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
90.25
買値
89.00
売値
91.31
出来高
481
89.92 日の範囲 90.72
84.98 52 週間の範囲 107.96
時価総額
前日終値
91.11
始値
90.64
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
745
発行済株式数
1,252,640,466
配当利回り
4.17%
PER
21.17
1 株当たり利益 (EPS)
4.31
歳入
43.07B
純利益
5.4B

Sanofi について

セクター
Health & Allied Services,nec
業界
Pharmaceutical Preparations
ウェブサイト
本社
Paris, Paris, Fra
設立
1994
Sanofi is listed in the Health & Allied Services sector of the イタリア証券取引所 with ticker 1SAN. The last closing price for Sanofi was 91.11 €. Over the last year, Sanofi shares have traded in a share price range of 84.98 € to 107.96 €.

Sanofi currently has 1,252,640,466 shares in issue. The market capitalisation of Sanofi is 114.13 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.17.

1SAN 最新ニュース

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées Le...

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Tolebrutinib designated Breakthrough Therapy by the FDA for...

Communiqué de presse : Examen accéléré accordé aux États-Unis à deux candidats-vaccins combinés pour la prévention de la grippe et du COVID-19

Communiqué de presse : Examen accéléré accordé aux États-Unis à deux candidats-vaccins combinés pour la prévention de la grippe et du COVID-19 Examen accéléré accordé aux États-Unis à deux...

Press Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US

Press Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US Two combination vaccine candidates for prevention of influenza...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.340.37815593371189.919287.48130090.61067374DE
4-1.6-1.7419706042591.8596.2887.4888691.36796929DE
12-11.49-11.293493218101.74104.2287.4874594.66112891DE
263.293.7833486660586.96107.9686.8188196.02889049DE
521.091.2225213189.16107.9684.9884693.11627232DE
1564.575.3338001867485.68107.9676.3697191.63274323DE
2600090.25107.9668148187.82933331DE

1SAN - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?
The current share price of Sanofi is 90.25 €
How many Sanofi shares are in issue?
Sanofi has 1,252,640,466 shares in issue
What is the market cap of Sanofi?
The market capitalisation of Sanofi is EUR 114.13B
What is the 1 year trading range for Sanofi share price?
Sanofi has traded in the range of 84.98 € to 107.96 € during the past year
What is the PE ratio of Sanofi?
The price to earnings ratio of Sanofi is 21.17
What is the cash to sales ratio of Sanofi?
The cash to sales ratio of Sanofi is 2.65
What is the reporting currency for Sanofi?
Sanofi reports financial results in EUR
What is the latest annual turnover for Sanofi?
The latest annual turnover of Sanofi is EUR 43.07B
What is the latest annual profit for Sanofi?
The latest annual profit of Sanofi is EUR 5.4B
What is the registered address of Sanofi?
The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017
What is the Sanofi website address?
The website address for Sanofi is www.sanofi.com
Which industry sector does Sanofi operate in?
Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WFTC26Finanzatech Spa
0.025 €
(26.26%)
40
WART28DeodatoGallery SpA
0.0558 €
(24.00%)
27.4k
WFAE25Fae Technology
0.50 €
(16.23%)
20
WSGC28SG Company SpA
0.0294 €
(13.51%)
1,000
WPOZ27Pozzi Milano Spa
0.102 €
(13.33%)
14.05k
WPSQ26Pasquarelli Auto SpA
0.0109 €
(-44.10%)
923
1CDECoeur Mining Inc
5.51 €
(-20.63%)
500
1WCHWacker Chemie AG
67.50 €
(-18.28%)
218
WTFINTrevi Finanziaria Industriale Spa
1.011 €
(-17.54%)
2.42k
EPHEPH SpA
0.1002 €
(-16.50%)
6.72k
TITTelecom Italia SpA
0.243 €
(-3.19%)
370.41M
ISPIntesa Sanpaolo Spa
3.841 €
(-0.31%)
137.21M
SPMSaipem Spa
2.484 €
(-6.02%)
64.72M
TITRTelecom Italia
0.2813 €
(-3.10%)
47.53M
ENELEnel Spa
6.804 €
(0.04%)
42.28M

最近閲覧した銘柄

Delayed Upgrade Clock